IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -343.30K | -2.79M | 1.18M | -3.33M | 731.00K |
| Total Depreciation and Amortization | 1.80K | 2.00K | 2.10K | 2.40K | 2.70K |
| Total Amortization of Deferred Charges | 360.20K | 95.10K | 295.20K | 285.20K | 279.20K |
| Total Other Non-Cash Items | -615.30K | 2.21M | -2.08M | 2.40M | -1.59M |
| Change in Net Operating Assets | 446.60K | 481.50K | 600.00K | 354.50K | 71.00K |
| Cash from Operations | -150.00K | 0.00 | 0.00 | -280.30K | -506.50K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 150.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 150.00K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | 0.00 | 0.00 | -280.30K | -506.50K |